Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Aspirin-Exacerbated Respiratory Disease

Although previous numbers for aspirin-exacerbated respiratory disease (AERD) have varied widely, new findings suggest that it is present in approximately 7% of the adult asthmatic patient population, with that number doubled in patients with severe asthma.

Lung Infections May Hamper Cancer Detection

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common.

Fetal BPA Exposure and Childhood Wheeze

Exposure in pregnancy to bisphenol A (BPA) may increase a child's risk of respiratory issues, with a 10-fold increase in the average amount of BPA in the mothers' urine linked to a nearly 55% increase in the odds of some type of wheezing in their children.

Asthma Risk and Job Loss Fear

Perceived job insecurity during an economic downturn may increase the risk of newly onset asthma.

Sense of Smell May Predict Mortality

Olfaction could predict 5-year mortality risk among older adults, suggests a new study.

FDA Warning on Asthma Drug

The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with Xolair.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.

New Drug Product: Breo Ellipta

Long term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema.

News

Ofev Launched for Idiopathic Pulmonary Fibrosis

Boehringer Ingelheim announced that Ofev (nintedanib) capsules are now available for the treatment of idiopathic pulmonary fibrosis (IPF).

Guideline on Prevention of Acute COPD Exacerbations Released

The American College of Chest Physicians (CHEST) and Canadian Thoracic Society (CTS) have developed a joint evidence-based guideline on preventing acute exacerbations of chronic obstructive pulmonary disease (COPD).

Two New Drugs for Idiopathic Pulmonary Fibrosis Approved

The Food and Drug Administration has approved Esbriet (pirfenidone; Genentech) and Ofev (nintedanib; Boehringer Ingelheim) for the treatment of idiopathic pulmonary fibrosis (IPF).

14 Million Smoking-Related Illnesses in U.S., CDC Estimates

Cigarette smoking accounts for approximately 14 million major medical conditions that plague the lives of U.S. adults, according to a new government report.

Featured courses from mycme

Asthma and COPD: Providing Optimal Management (Pharmacology Credit)External web site

This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...

CE 1.50 Credits

Red flags - Respiratory tract infectionsExternal web site

Red flags - Respiratory tract infections

0.50 Credits

Sign Up for Free e-newsletters